Raveen Parboosing

Biographic Data

ID9068827
NAMERaveen Parboosing
GIVEN NAMESRaveen
FAMILY NAMEParboosing
SIGNATUREPARBOOSING R
AFFILIATIONSNational Health Laboratory Service
ORCID0000-0002-5476-1011
VERIFIEDNo
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2012
LATEST PUBLICATION YEAR2024
H-INDEX0

  • Geospatial and temporal mapping of detectable HIV-1 viral loads amid dolutegravir rollout in KwaZulu-Natal, South Africa

    Open AccessLilishia Gounder, Andrew Tomita et al.ARTICLEPLOS Global Public Health2024

    South Africa rolled out dolutegravir (DTG) as first-line antiretroviral therapy (ART) in December 2019 to overcome high rates of pretreatment non-nucleoside reverse transcriptase inhibitor drug resistance. In the context of transition to DTG-based ART, this study spatiotemporally analysed detectable HIV viral loads (VLs) prior to- and following DTG rollout in public-sector healthcare facilities in KwaZulu-Natal (KZN) province, the epicentre of th…

  • In Vitro Testing of African Traditional Medicines for Cytotoxic, Immune Modulatory and Anti-HIV Activities

    Open AccessNceba Gqaleni, N Gqalenia et al.ARTICLEAfrican Journal of Traditional…2012

    African Traditional Medicines (ATMs) serve as a major source of primary healthcare for African people. The reasons for their use range from easy access, affordability, beliefs in traditional systems and long term safety. ATMs have been used to treat individuals infected with HIV and therefore need scientific validation; a view supported by Traditional Health Practitioners (THPs). This study aimed to evaluate the in vitro cytotoxicity, immune modu…